Reduced LPA expression after peroxisome proliferator-activated receptor alpha (PPARα) activation in LPA-YAC transgenic mice

Pathophysiology

Volumn 11, Issue 4, 2005, Pages 201-208

  Teivainen Laedre, Päivi A ^a,b   Eliassen, Knut A ^c   Sletten, Marit ^a,b   Smith, Adrian J ^c   Berg, Kåre ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

Apo(a); Fibrates; LPA; Transgenic mice

Indexed keywords

FARNESOID X RECEPTOR; FENOFIBRATE; LIPOPROTEIN A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAY REGION BINDING SITE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA BINDING; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC ANALYSIS; LIPID DIET; LIPOPROTEIN A GENE; LIPOPROTEIN BLOOD LEVEL; LIVER; MOUSE; NONHUMAN; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TISSUE DISTRIBUTION; TRANSGENIC MOUSE; YEAST ARTIFICIAL CHROMOSOME;

EID: 17044371505     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2004.12.002     Document Type: Article

References (41)

1. C. Brunner, H.G. Kraft, G. Utermann, and H.J. Muller Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly Proc. Natl. Acad. Sci. U.S.A. 90 1993 11643 11647
2. J.W. McLean, J.E. Tomlinson, W.J. Kuang, D.L. Eaton, E.Y. Chen, G.M. Fless, A.M. Scanu, and R.M. Lawn cDNA sequence of human apolipoprotein(a) is homologous to plasminogen Nature 330 1987 132 137
3. P. Magnaghi, E. Citterio, N. Malgaretti, F. Acquati, S. Ottolenghi, and R. Taramelli Molecular characterisation of the human apo(a)-plasminogen gene family clustered on the telomeric region of chromosome 6 (6q26-27) Hum. Mol. Genet. 3 1994 437 442
4. K. Makino, A. Abe, S. Maeda, A. Noma, M. Kawade, and O. Takenaka Lipoprotein(a) in nonhuman primates. Presence and characteristics of Lp(a) immunoreactive materials using anti-human Lp(a) serum Atherosclerosis 78 1989 81 85
5. P.M. Laplaud, L. Beaubatie, S.C. Rall Jr., G. Luc, and M. Saboureau Lipoprotein[a] is the major apoB-containing lipoprotein in the plasma of a hibernator, the hedgehog (Erinaceus europaeus) J. Lipid Res. 29 1988 1157 1170
6. K.A. Frazer, G. Narla, J.L. Zhang, and E.M. Rubin The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice Nat. Genet. 9 1995 424 431
7. G. Chiesa, H.H. Hobbs, M.L. Koschinsky, R.M. Lawn, S.D. Maika, and R.E. Hammer Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a) J. Biol. Chem. 267 1992 24369 24374
8. B.A. Clevidence, J.T. Judd, E.J. Schaefer, J.L. Jenner, A.H. Lichtenstein, R.A. Muesing, J. Wittes, and M.E. Sunkin Plasma lipoprotein (a) levels in men and women consuming diets enriched in saturated, cis-, or trans-monounsaturated fatty acids Arterioscler. Thromb. Vasc. Biol. 17 1997 1657 1661
9. T. Huby, V. Afzal, C. Doucet, R.M. Lawn, E.L. Gong, M.J. Chapman, J. Thillet, and E.M. Rubin Regulation of the expression of the apolipoprotein(a) gene: evidence for a regulatory role of the 5′ distal apolipoprotein(a) transcription control region enhancer in yeast artificial chromosome transgenic mice Arterioscler. Thromb. Vasc. Biol. 23 2003 1633 1639
10. P.A. Teivainen, K.A. Eliassen, K. Berg, K. Torsdalen, and A. Svindland Atherogenesis and vascular calcification in mice expressing the human LPA gene Pathophysiology 11 2004 113 120
11. F. Acquati, R. Hammer, B. Ercoli, V. Mooser, R. Tao, V. Ronicke, A. Michalich, G. Chiesa, R. Taramelli, H.H. Hobbs, and H.J. Muller Transgenic mice expressing a human apolipoprotein[a] allele J. Lipid Res. 40 1999 994 1006
12. P.A. Teivainen, K.A. Eliassen, E.M. Rubin, S. Djurovic, and K. Berg Human apoB contributes to increased serum total apo(a) level in LPA transgenic mice Lipids Health Dis. 3 2004 8
13. D.W. Russell, and K.D. Setchell Bile acid biosynthesis Biochemistry 31 1992 4737 4749
14. J.Y.L. Chiang Regulation of bile acid synthesis Front. Biosci. 3 1998 D176 D193
15. S. Gupta, W.M. Pandak, and P.B. Hylemon LXR alpha is the dominant regulator of CYP7A1 transcription Biochem. Biophys. Res. Commun. 293 2002 338 343
16. B. Goodwin, S.A. Jones, R.R. Price, M.A. Watson, D.D. McKee, L.B. Moore, C. Galardi, J.G. Wilson, M.C. Lewis, M.E. Roth, P.R. Maloney, T.M. Willson, and S.A. Kliewer A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis Mol. Cells 6 2000 517 526
17. P. Teivainen, K. Eliassen, S. Djurovic, and K. Berg Effect of cholesterol feeding on apo(a), CYP7A1 and LXR alpha expression in LPA transgenic mice Atheroscler. Suppl. 4 2003 296
18. B. Staels, J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf, and J.C. Fruchart Mechanism of action of fibrates on lipid and lipoprotein metabolism Circulation 98 1998 2088 2093
19. B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocr. Rev. 20 1999 649 688
20. D.P. Wade, L.H. Puckey, B.L. Knight, F. Acquati, A. Mihalich, and R. Taramelli Characterization of multiple enhancer regions upstream of the apolipoprotein(a) gene J. Biol. Chem. 272 1997 30387 30399
21. G. Dahlen, T. Gillnas, A.L. Borresen, K. Berg, and C. Ericson Effect of gemfibrozil on serum lipid levels Artery 7 1980 224 231
22. D.M. Neele, A. Kaptein, H. Huisman, E.C. de Wit, and H.M. Princen No effect of fibrates on synthesis of apolipoprotein(a) in primary cultures of cynomolgus monkey and human hepatocytes: apolipoprotein A-I synthesis increased Biochem. Biophys. Res. Commun. 244 1998 374 378
23. P.H. Jones, H.J. Pownall, W. Patsch, J.A. Herd, J.A. Farmer, C. Payton-Ross, K.T. Kimball, A.M. Gotto, and J.D. Morrisett Effect of gemfibrozil on levels of lipoprotein[a] in type II hyperlipoproteinemic subjects J. Lipid Res. 37 1996 1298 1308
24. S.J. Bredie, H.T. Westerveld, H.C. Knipscheer, T.W. de Bruin, J.J. Kastelein, and A.F. Stalenhoef Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia Neth. J. Med. 49 1996 59 67
25. M.C. Hunt, Y.Z. Yang, G. Eggertsen, C.M. Carneheim, M. Gafvels, C. Einarsson, and S.E. Alexson The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis J. Biol. Chem. 275 2000 28947 28953
26. S.M. Post, H. Duez, P.P. Gervois, B. Staels, F. Kuipers, and H.M. Princen Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression Arterioscler. Thromb. Vasc. Biol. 21 2001 1840 1845
27. K. Berg, A. Svindland, A.J. Smith, R.M. Lawn, S. Djurovic, A. Alestrom, P. Alestrom, and K. Eliassen Spontaneous atherosclerosis in the proximal aorta of LPA transgenic mice on a normal diet Atherosclerosis 163 2002 99 104
28. Reference values for clinical chemical analytes, in: W.F. Loeb, F.W. Quimby (Eds.), The Clinical Chemistry of Laboratory Animals, Pergamon Press, New York, 1989, pp. 415-495.
29. C. Tomkiewicz, F. Muzeau, A.D. Edgar, R. Barouki, and M. Aggerbeck Opposite regulation of the rat and human cytosolic aspartate aminotransferase genes by fibrates Biochem. Pharmacol. 67 2004 213 225
30. A.D. Edgar, C. Tomkiewicz, P. Costet, C. Legendre, M. Aggerbeck, J. Bouguet, B. Staels, C. Guyomard, T. Pineau, and R. Barouki Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway Toxicol. Lett. 98 1998 13 23
31. S.S. Lee, T. Pineau, J. Drago, E.J. Lee, J.W. Owens, D.L. Kroetz, P.M. Fernandez-Salguero, H. Westphal, and F.J. Gonzalez Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators Mol. Cell. Biol. 15 1995 3012 3022
32. L.H. Puckey, and B.L. Knight Interaction of oestrogen and peroxisome proliferator-activated receptors with apolipoprotein(a) gene enhancers Biochem. J. 366 2002 157 163
33. M. Makishima, A.Y. Okamoto, J.J. Repa, H. Tu, R.M. Learned, A. Luk, M.V. Hull, K.D. Lustig, D.J. Mangelsdorf, and B. Shan Identification of a nuclear receptor for bile acids Science 284 1999 1362 1365
34. D.J. Parks, S.G. Blanchard, R.K. Bledsoe, G. Chandra, T.G. Consler, S.A. Kliewer, J.B. Stimmel, T.M. Willson, A.M. Zavacki, D.D. Moore, and J.M. Lehmann Bile acids: natural ligands for an orphan nuclear receptor Science 284 1999 1365 1368
35. J.Y. Chiang, R. Kimmel, C. Weinberger, and D. Stroup Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription J. Biol. Chem. 275 2000 10918 10924
36. B.A. Laffitte, H.R. Kast, C.M. Nguyen, A.M. Zavacki, D.D. Moore, and P.A. Edwards Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor J. Biol. Chem. 275 2000 10638 10647
37. L.A. Pennacchio, M. Olivier, J.A. Hubacek, J.C. Cohen, D.R. Cox, J.C. Fruchart, R.M. Krauss, and E.M. Rubin An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing Science 294 2001 169 173
38. N. Vu-Dac, P. Gervois, H. Jakel, M. Nowak, E. Bauge, H. Dehondt, B. Staels, L.A. Pennacchio, E.M. Rubin, J. Fruchart-Najib, and J.C. Fruchart Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators J. Biol. Chem. 278 2003 17982 17985
39. P.R. Maloney, D.J. Parks, C.D. Haffner, A.M. Fivush, G. Chandra, K.D. Plunket, K.L. Creech, L.B. Moore, J.G. Wilson, M.C. Lewis, S.A. Jones, and T.M. Willson Identification of a chemical tool for the orphan nuclear receptor FXR J. Med. Chem. 43 2000 2971 2974
40. M. Watanabe, S.M. Houten, L. Wang, A. Moschetta, D.J. Mangelsdorf, R.A. Heyman, D.D. Moore, and J. Auwerx Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c J. Clin. Invest. 113 2004 1408 1418
41. E. Sanguino, M. Ramon, L. Michalik, W. Wahli, M. Alegret, R.M. Sanchez, M. Vazquez-Carrera, and J.C. Laguna Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPARalpha Biochem. Pharmacol. 67 2004 157 166